Finance

Lists
SHUKRAPHAR:NSE
Shukra Pharmaceuticals Ltd
₹53.85
-2.60%
(-1.44) 1D
Sep 16, 11:02:07 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SHUKRAPHAR...
Open
₹56.49
High
₹56.49
Low
₹52.29
Mkt. cap
23.66B
Avg. vol.
0.00
Volume
327.47K
P/E ratio
69.05
52-wk high
₹65.26
52-wk low
₹26.30
EPS
₹0.78
No. of employees
211
Open
₹56.49
High
₹56.49
Low
₹52.29
Mkt. cap
23.66B
Avg. vol.
0.00
Volume
327.47K
P/E ratio
69.05
52-wk high
₹65.26
52-wk low
₹26.30
EPS
₹0.78
No. of employees
211
About Shukra Pharmaceuticals Ltd
CEO-
Employees211
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiteshukrapharmaceuticals.com
Last report
Aug 12, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
235.22M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
75.90M
391.35M
63.24M
235.22M
Cost of goods sold
20.05M
71.34M
59.40M
-15.35M
Cost of revenue
20.05M
71.34M
59.40M
-15.35M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.93M
26.47M
3.72M
43.89M
Operating expense
51.02M
48.88M
-2.56M
64.56M
Total operating expenses
71.07M
120.22M
56.84M
49.21M
Operating income
4.83M
271.13M
6.40M
186.01M
Other non operating income
1.00K
1.00K
1.00K
-
EBT including unusual items
1.98M
268.31M
3.82M
181.72M
EBT excluding unusual items
1.98M
268.31M
3.82M
181.72M
Income tax expense
-21.80M
64.67M
20.98M
52.13M
Effective tax rate
-1,098.04%
24.10%
549.74%
28.69%
Other operating expenses
20.99M
14.02M
-16.35M
9.85M
Net income
23.78M
203.65M
-17.16M
129.58M
Net profit margin
31.33%
52.04%
-27.14%
55.09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.85M
-2.82M
-2.58M
-4.30M
Net interest expenses
-2.85M
-2.82M
-2.58M
-4.30M
Depreciation and amortization charges
8.09M
8.39M
10.08M
10.82M
EBITDA
12.82M
278.64M
15.00M
194.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps